isatin derivatives (Spanish National Research Council)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Nameisatin derivatives (Spanish National Research Council)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLeucine-rich repeat serine/threonine-protein kinase 2 inhibitors
TargetsLeucine-rich repeat serine/threonine-protein kinase 2
Therapy Area/IndicationsNerve DegenerationInflammationAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSpanish National Research Council
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSpanish National Research Council
Active IndicationsN/A
Inactive IndicationsNerve DegenerationInflammationAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A